跳到主要导航 跳到搜索 跳到主要内容

IL-33 at the Crossroads of Metabolic Disorders and Immunity

  • Lei Tu
  • , Lijing Yang*
  • *此作品的通讯作者
  • Huazhong Univ Sci & Technol

科研成果: 期刊稿件 › 综述 › 同行评审

19 引用 (Scopus)

摘要

As a cytokine in interleukin-1(IL-1) family, interleukin-33(IL-33) usually exists in the cytoplasm and cell nucleus. When the cells are activated or damaged, IL-33 can be secreted into extracellular and regulate the functions of various immune cells through binding to its specific receptor suppression of tumorigenicity 2 (ST2). Except regulating the function of immune cells including T cells, B cells, dendritic cells (DCs),macrophages, mast cells, and innate lymphoid cells, IL-33 also plays an important role in metabolic diseases and has received an increasing attention. This review summarizes the regulation of IL-33 on different immune cells in lipid metabolism, which will help to understand the pathology of abnormal lipid metabolic diseases, such as atherosclerosis and type 2 diabetes.
源语言英语
期刊论文编号26
页数5
期刊FRONTIERS IN ENDOCRINOLOGY
卷10
DOI
出版状态已出版 - 30 1月 2019

基金资助

This work was supported by the National Natural Science Foundation of China 81700490 to LT.

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

关键词

  • IL-33
  • metabolism
  • diabetes
  • innate & adaptive immune response
  • ST2

收录

  • SCIE

学术指纹

探究 'IL-33 at the Crossroads of Metabolic Disorders and Immunity' 的科研主题。它们共同构成独一无二的学术指纹。

引用此